GGrantIndex
Sort

46,585 grants matching heart failure

Microfabricated Vascularized 3D Tissue Engineered Constructs

$436,904
Ali Khademhosseini · Brigham And Women'S Hospital · R01 · FY2009 · HL

Determinants of cardioprotection by circulating prohibitin-1 during sepsis

$436,894
Ethan John Anderson · University Of Iowa · R01 · FY2024 · HL

Phospholipids and Mitochondrial Function

$436,876
William Dowhan · University Of Texas Hlth Sci Ctr Houston · R01 · FY2008 · GM

Quantifying the coordinated dynamics of single-gene transcription and translation in living cells

$436,838
Timothy Stasevich · Colorado State University · R35 · FY2021 · GM

Characterizing the Role of the Dorsomedial Hypothalamic Nucleus and Raphe Pallidus in the Cardiogenic Sympathetic Afferent Reflex

$436,800
Matthew Ralph Zahner · East Tennessee State University · R15 · FY2019 · HL

HDL Heterogeneity and Function, Statin Therapy, and CVD Outcomes

$436,786
Samia Mora · Brigham And Women'S Hospital · R01 · FY2015 · HL

Signal transduction mechanisms that mediate normal and pathologic angiogenesis

$436,763
Jinjiang Pang · University Of Rochester · R01 · FY2021 · HL

Using CBPR to Implement Smoking Cessation in an Urban American Indian Community

$436,724
Christine Makosky Daley · University Of Kansas Medical Center · R24 · FY2009 · MD

Thrombospondin 4 regulates adaptive ER stress response

$436,655
Jeffery D Molkentin · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · HL

Ca2+ Regulation in Newly Formed Ventricular Myocytes

$436,653
Steven R Houser · Temple Univ Of The Commonwealth · R37 · FY2012 · HL

Targeting Sympathetic Overactivity in CKD patients: Mechanisms & Novel Therapies

$436,639
Paul J Fadel · University Of Texas Arlington · R01 · FY2019 · HL

Predicting CHD Events in Black and White Women

$436,632
Jean C McSweeney · Univ Of Arkansas For Med Scis · R01 · FY2007 · NR

Role of TET dioxygenase associated immune mechanisms in cardiac injury and repair

$436,631
Yun Huang · Texas A&M University Health Science Ctr · R01 · FY2020 · HL

CARDIAC GENE THERAPY

$436,564
Hugh Lee Sweeney · University Of Pennsylvania · P01 · FY2008 · HL

Targeting Novel BMPR2 modifiers in Pulmonary Hypertension with Repurposed Drugs

$436,538
Edda Frauke Spiekerkoetter · Stanford University · R01 · FY2020 · HL

Targeting Novel BMPR2 modifiers in Pulmonary Hypertension with Repurposed Drugs

$436,538
Edda Frauke Spiekerkoetter · Stanford University · R01 · FY2018 · HL

Targeting Novel BMPR2 modifiers in Pulmonary Hypertension with Repurposed Drugs

$436,538
Edda Frauke Spiekerkoetter · Stanford University · R01 · FY2019 · HL

SURGICAL TREATMENT OF CARDIAC ARRHYTHMIAS

$436,532
Ralph J Damiano · Washington University · R01 · FY2009 · HL

Training in Cardiovascular Translational Research

$436,469
Andrew R Marks · Columbia University Health Sciences · T32 · FY2015 · HL

Intercellular Communication and Cardiac Arrhythmias

$436,463
Gregory E Morley · New York University School Of Medicine · R01 · FY2009 · HL

Coronary to Myocyte Signaling

$436,353
Thomas H Hintze · New York Medical College · P01 · FY2007 · HL

Defining 4D Ventricular Mechanics in Acquired and Congenital Heart Disease

$436,324
David J. Sahn · Oregon Health & Science University · R01 · FY2010 · HL

Nitric Oxide as a Modifier of Oxidative Stress

$436,316
David A Wink · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

How immunodominant Fc peptide epitopes expand natural regulatory T cells and downregulate inflammation

$436,272
Alessandra I Franco · University Of California, San Diego · R01 · FY2020 · AI

CRT and Mitochondrial Function and Proteome Post-Translational Modifications

$436,227
Jennifer E Van Eyk · Johns Hopkins University · P01 · FY2012 · HL